Delivery Order SPE2DB22D1017-SPE2DB24FE7VL
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,469.91 firm fixed-price delivery order is for the supply of 4564492478 - Pirfenidone 267 mg tablets. The contract has an ultimate completion date of May 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Pirfenidone 801 mg tablets. The contract, valued at $4,345.29, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 29, 2024. The contract was awarded on April 26, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,452.41 firm fixed-price delivery order is for the supply of 4562731597 - PIRFENIDONE 267 MG TABLET 270S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Cencora, Inc., valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award, with the ID SPE2DX15D3001|SPE2DX24F4QJ8, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,357.71 Firm Fixed Price delivery order is for the supply of 4563004145 - PIRFENIDONE 267 MG TABLET 270S. The contract has no set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,324.85, is for the delivery of Pirfenidone 267 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves...
- This federal contract award, SPE2DX15D3014|SPE2DX24FXCYL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,231.59 firm fixed-price delivery order is for the supply of 4563731426 - Pirfenidone 801 mg Tablets. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This delivery order contract, valued at $5,338.00, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Pirfenidone 267 mg capsules and has an ultimate completion date of August 21, 2023. The contract type is firm fixed price. This award is not associated with a set-aside program. The contract is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,973.70 delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The $1,892.97 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,364.13 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora holds with the DLA. This IDC serves as the primary vehicle for Cencora to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE7VLDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of Pirfenidone 801 mg tablets to the Defense Logistics Agency (DLA). The $10,306.63 Firm Fixed Price delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. As a major pharmaceutical distributor, Amerisourcebergen Drug Corp plays a critical role in supplying essential medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 11/1/23 |